ARTICLE SUMMARY:
Eyeing the success of Glaukos Corp. and other up-and-coming companies developing minimally invasive surgeries for glaucoma, Sanoculis wants to go one step further, with a procedure that creates drainage for aqueous humor without leaving behind an implant. In creating minimal damage, the start-up hopes to offer a safe and repeatable procedure.
There’s hope for glaucoma sufferers—4.2 million people in the US and 78 million worldwide—who, without effective treatments, would progressively and irreversibly lose their eyesight.
